HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytomegalovirus infection in immunocompromised guinea pigs: a model for testing antiviral agents in vivo.

Abstract
An experimental model for testing antiviral agents against severe cytomegalovirus (CMV) infection in immunocompromised hosts was developed. The model consisted of cyclophosphamide (Cy) treatment of CMV-infected guinea pigs to simulate CMV infection in immunodeficient individuals. Of the 3 Cy regimens tested, a single 300 mg/kg dose administered one day after virus inoculation resulted in the most severe CMV infection considering mortality rates, mean day of death and loss of body weight. Evaluation of responses to both T and B cell mitogens suggested that the severe and lethal CMV infection resulted from the combined immunosuppressive effect of Cy and CMV. The nucleoside analog [9-(1-3-dihydroxy-2-propoxymethyl)guanine (DHPG) was used to assess the usefulness of the CMV-infected immunocompromised host model. DHPG (100 mg/kg/day for 8 days) prevented death but did not reduce virus infectivity titers in blood of Cy-treated, CMV-infected guinea pigs. This model of CMV infection in immunocompromised guinea pig is a relevant and convenient experimental tool for the assessment of candidate anti-CMV agents under well-defined experimental conditions, such as appropriate CMV inoculum and Cy regimen.
AuthorsM J Aquino-de Jesus, B P Griffith
JournalAntiviral research (Antiviral Res) Vol. 12 Issue 4 Pg. 181-93 (Nov 1989) ISSN: 0166-3542 [Print] Netherlands
PMID2559656 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antiviral Agents
  • Concanavalin A
  • Cyclophosphamide
  • Ganciclovir
Topics
  • Acute Disease
  • Animals
  • Antiviral Agents (therapeutic use)
  • Cells, Cultured
  • Concanavalin A (pharmacology)
  • Cyclophosphamide (administration & dosage, pharmacology)
  • Cytomegalovirus Infections (drug therapy, immunology)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Female
  • Ganciclovir (therapeutic use)
  • Guinea Pigs
  • Immunologic Deficiency Syndromes (drug therapy)
  • Lymphocyte Activation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: